SEATTLE, Aug. 4, 2022 /PRNewswire/ -- Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX: VHT), a global health technology software leader providing an integrated platform for ...
LYNNWOOD, Wash., Nov. 4, 2024 /PRNewswire/ -- Volpara Health, a Lunit company and a global leader in software for the early detection of cancer, today announced a significant contract with the U.S.
“AI in diagnostics is where the future is going to be. And I think our kids will look back on healthcare now and think, ‘Oh my gosh, radiologists used to just read those images on their own?’” ...
Lunit (KRX:32813), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 21 studies featuring its AI solutions will be presented at the European Congress of ...
Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, ...
SAN DIEGO, CA, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- CureMetrix ®, a leader in AI-based solutions for mammography, announces that they have entered ...
LYNNWOOD, Wash., Oct. 7, 2024 /PRNewswire/ -- As we begin this year's Breast Cancer Awareness Month, Volpara Health, a Lunit company and a global leader in software for the early detection of cancer, ...
Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care SEOUL, South ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results